RealFeedApp Petrelintide reduced weight by up to 9.2% over 28 weeks
Petrelintide achieved up to 9.2% weight loss over 28 weeks in a Phase 2 trial involving 220 participants with obesity and type 2 diabetes. Only 1.9% of participants discontinued due to stomach-related side effects.
- Field
- drugs and trials
- What they did
- In a phase 2 trial, the drug petrelintide (Amylin) helped participants with obesity and type 2 diabetes lose up to 9.2% of their body weight over 28 weeks.
- Why it matters
- This could be useful for people with diabetes because the drug caused very few side effects, with only 1.9% of participants stopping due to stomach-related issues.
#petrelintide#amylin#weight loss#diabetes#zealand pharma
